Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Tissue expansion for head and neck reconstruction has good blood supply and doesn't need capsule removal, but expect temporary hair loss with normal growth resuming after 6-8 months.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Veterinarians could test positive for ketamine from work exposure, not just substance abuse.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Finasteride for hair loss may cause painless bleeding in urine and semen.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

A spayed dog with vaginal bone structures causing infection was successfully treated by removing the bones and administering medication.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Finasteride reduces prostate size and PSA levels in young patients.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.